Literature DB >> 3902903

Changes in plasma fibronectin during allogeneic bone marrow transplantation.

D R Norfolk, M Bowen.   

Abstract

Plasma fibronectin concentrations were measured serially in nine patients undergoing allogeneic bone marrow transplantation. Concentrations were reduced by conditioning treatment and episodes of bacterial infection. Acute graft versus host disease may exacerbate or prolong this process. Reduced plasma fibronectin concentrations impair the function of the mononuclear phagocyte system and the maintenance of capillary endothelial integrity and may thus contribute to the morbidity and mortality in patients undergoing bone marrow transplantation.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3902903      PMCID： PMC499466          DOI： 10.1136/jcp.38.10.1185

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  12 in total

1.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

2.  The effect of starvation and repletion on plasma fibronectin in man.

Authors:  R L Scott; P R Sohmer; M G MacDonald
Journal:  JAMA       Date:  1982-10-22       Impact factor: 56.272

3.  Plasma fibronectin in acute leukaemia.

Authors:  B J Boughton; A Simpson
Journal:  Br J Haematol       Date:  1982-07       Impact factor: 6.998

4.  Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia.

Authors:  H G Prentice; H A Blacklock; G Janossy; K F Bradstock; D Skeggs; G Goldstein; A V Hoffbrand
Journal:  Lancet       Date:  1982-03-27       Impact factor: 79.321

5.  Fibronectin as an opsonic regulator of monocyte phagocytosis.

Authors:  A W Simpson; B J Boughton
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

6.  Plasma fibronectin in myeloproliferative disorders and chronic granulocytic leukaemia.

Authors:  D R Norfolk; M Bowen; B E Roberts; J A Child
Journal:  Br J Haematol       Date:  1983-10       Impact factor: 6.998

7.  Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies.

Authors:  T M Saba; G D Niehaus; W A Scovill; F A Blumenstock; J C Newell; J Holman; S R Powers
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

8.  Binding of fibronectin by the acute phase reactant C-reactive protein.

Authors:  E M Salonen; T Vartio; K Hedman; A Vaheri
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

9.  Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function.

Authors:  T M Saba; E Jaffe
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

10.  Failure of fibronectin as an opsonin in the host defence system: a case of competitive self inhibition?

Authors:  R A Brown
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.